Brain amyloid-β oligomers in ageing and Alzheimer's disease. - Wikidata - awgldk - TriplyDB

Brain amyloid-β oligomers in ageing and Alzheimer's disease.

Brain amyloid-β oligomers in ageing and Alzheimer's disease.

http://www.wikidata.org/entity/Q30539133

about

The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy Calcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's Disease Fluid Biomarkers in Clinical Trials of Alzheimer's Disease Therapeutics Early failure of the default-mode network and the pathogenesis of Alzheimer's disease Breaking the Code of Amyloid-β Oligomers On the Environmental Factors Affecting the Structural and Cytotoxic Properties of IAPP Peptides Is L-methionine a trigger factor for Alzheimer's-like neurodegeneration?: Changes in Aβ oligomers, tau phosphorylation, synaptic proteins, Wnt signaling and behavioral impairment in wild-type mice Treatment of beta amyloid 1-42 (Aβ(1-42))-induced basal forebrain cholinergic damage by a non-classical estrogen signaling activator in vivo IVIg protects the 3xTg-AD mouse model of Alzheimer’s disease from memory deficit and Aβ pathology Molecular Structure of Aggregated Amyloid-β: Insights from Solid-State Nuclear Magnetic Resonance Three dimensions of the amyloid hypothesis: time, space and 'wingmen'APOE-modulated Aβ-induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective Analyzing dendritic spine pathology in Alzheimer's disease: problems and opportunities Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity DBA/2J genetic background exacerbates spontaneous lethal seizures but lessens amyloid deposition in a mouse model of Alzheimer's disease.Plaque-associated lipids in Alzheimer's diseased brain tissue visualized by nonlinear microscopy Chronic adiponectin deficiency leads to Alzheimer's disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice.Highly potent soluble amyloid-β seeds in human Alzheimer brain but not cerebrospinal fluid Physiological IgM class catalytic antibodies selective for transthyretin amyloid.The essential role of p53-up-regulated modulator of apoptosis (Puma) and its regulation by FoxO3a transcription factor in β-amyloid-induced neuron death.The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases Tat-haFGF14-154 Upregulates ADAM10 to Attenuate the Alzheimer Phenotype of APP/PS1 Mice through the PI3K-CREB-IRE1α/XBP1 Pathway.Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease.Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies.Smoking and increased Alzheimer's disease risk: a review of potential mechanisms Alzheimer's disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of PPARs.Knock-in of human BACE1 cleaves murine APP and reiterates Alzheimer-like phenotypes Development of a novel cellular model of Alzheimer's disease utilizing neurosphere cultures derived from B6C3-Tg(APPswe,PSEN1dE9)85Dbo/J embryonic mouse brain Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation.Disruption of amyloid plaques integrity affects the soluble oligomers content from Alzheimer disease brains.Multifunctional Effects of Mangosteen Pericarp on Cognition in C57BL/6J and Triple Transgenic Alzheimer's Mice.Longitudinal testing of hippocampal plasticity reveals the onset and maintenance of endogenous human Aß-induced synaptic dysfunction in individual freely behaving pre-plaque transgenic rats: rapid reversal by anti-Aß agents.Increased Alzheimer's disease-like pathology in the APP/ PS1ΔE9 mouse model lacking Nrf2 through modulation of autophagy The elusive nature and diagnostics of misfolded Aβ oligomers.Specific amyloid β clearance by a catalytic antibody construct.Characterization of a Novel Mouse Model of Alzheimer's Disease--Amyloid Pathology and Unique β-Amyloid Oligomer Profile.Amyloid polymorphism: structural basis and neurobiological relevance.Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease Aβ43 is neurotoxic and primes aggregation of Aβ40 in vivo.

P2860

Q26747107-549ACFEB-082E-4F32-AFEF-8CB43468F1C7 Q26747527-F5496863-9F99-4ED1-93B1-38C6B67E1C79 Q26784569-32E5D17A-8EBF-4249-AC4B-D7821F1876E2 Q26862463-950EE36B-746A-4670-83E4-10037549C663 Q26862630-7D61D4FF-7F0D-4FBD-B093-5BE52C4E5EEC Q27022467-0D59E7BF-AD38-4492-B733-D97491CA7A66 Q27301311-B092939F-97D2-485F-832A-D668C50A2330 Q27349070-40DD4B19-AD1C-4F8F-A361-7F3684A2E773 Q27497796-B9F663A9-BC1D-4160-B377-076F90F75978 Q28066391-55BEDC00-BC82-4927-A19C-E72A0C64B580 Q28082768-913ED374-0D41-48DC-A693-F152C0BD7128 Q28085213-7D2C697A-909C-4380-AE15-9134133C43AE Q28087158-F8428678-3166-4256-BA2E-97F81B957C74 Q28544876-33E7CF72-4C04-4DA8-94C4-C3AAF6EB6688 Q29465470-578826F7-546E-4672-8444-A02699D54CBF Q30412535-F9E4F374-507B-4863-83AB-4DF2353D9C43 Q30662619-10D397DE-7D35-42B2-B546-C6B55CDDE2DB Q30829817-B205EE83-022F-4236-8518-9F80015ADD89 Q30842997-DD36F398-759C-4121-8E9E-3E817D4E43A1 Q33676625-18162E90-8663-404A-9901-DFBDFFF0D5E8 Q33677114-60C23781-57B9-4437-AF97-5C748741AB15 Q33692255-8386F0FD-CFF7-46DC-BBC1-31D305DB69B2 Q33726281-D9FD6879-0A51-4294-AE9A-AF915602F595 Q33745617-CF464DB9-8750-4AAC-ACB8-FE3A84A98DC7 Q33893017-1463D7B7-8379-401F-AA95-11BA99CB829A Q33902721-D763EC9E-8057-43AE-B784-431F5FFABB72 Q33959032-3CB92F47-FCD0-4D6F-BD42-FB13605377F3 Q34006919-38F235E2-9427-4B74-BEE2-209BBE3070DC Q34063838-EDBB548D-4C02-4CCD-939C-308CA7C1FE50 Q34227162-0BD2A698-A072-466A-8D18-F78C781277AC Q34654255-F470BA84-DB6B-43C5-8701-967009EF88AF Q34710160-E714328D-4048-47C1-9493-98DF27CBA8FC Q34950867-57EB358C-CB21-47FC-BFDB-86849B16D466 Q35044490-71E73C1D-CD9B-4019-8707-A440ACE80FBF Q35194588-86808BAF-DA67-4600-BAD4-7AA1E1BA5B76 Q35451085-35B04A23-144C-495E-BF4B-D95BB863F871 Q35577702-7CCD825E-385F-437D-A2D9-4CA651D9A2A2 Q35586308-61A0AAF9-A423-4253-840B-BBCF4EBD09FC Q35643397-285C6D06-6169-4D49-A9F2-94FAA5AC425E Q35748168-42B20EEF-2C57-45B9-BEF5-351BC9B347F7

P2860

Brain amyloid-β oligomers in ageing and Alzheimer's disease.

http://www.wikidata.org/entity/Q30539133

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Brain amyloid-β oligomers in ageing and Alzheimer's disease.

@ast

Brain amyloid-β oligomers in ageing and Alzheimer's disease.

@en

type

label

Brain amyloid-β oligomers in ageing and Alzheimer's disease.

@ast

Brain amyloid-β oligomers in ageing and Alzheimer's disease.

@en

prefLabel

Brain amyloid-β oligomers in ageing and Alzheimer's disease.

@ast

Brain amyloid-β oligomers in ageing and Alzheimer's disease.

@en

P1433

Q30539133-0D1480C4-1C33-48FE-AB82-D312891C7CB7

P1476

Q30539133-D5345D0E-782F-4216-961D-E9737666A6B7

P2093

Q30539133-0DB73EFC-6FCD-4DBB-A55A-BEECDCB2D677

Q30539133-0F3541E0-A261-42D8-8745-8919866DF53A

Q30539133-40C611C9-A28A-465F-BD63-446A49C5D897

Q30539133-7F997207-E91E-4672-9670-09643CE2B968

Q30539133-94D9F84E-AAEC-4170-B5A2-3EC319097A09

Q30539133-DF765E4A-EFC2-431B-BAA3-C967BA968B52

P2860

Q30539133-00E50F03-3D8C-4908-BAA6-78BDB446CE0E

Q30539133-0124C62E-6D1E-47EF-AB83-9C4D03F659B3

Q30539133-0613BCC8-91F6-485F-902E-EB7643871420

Q30539133-09DA205C-201A-47F0-9199-45B2DE2A58CE

Q30539133-0B010D8F-EABC-4961-A2ED-D5AD429A9778

Q30539133-11E02EAB-80DA-4776-870A-625AFD762F9E

Q30539133-15F6E5AE-F2DB-4793-A0C1-5A352289A71F

Q30539133-162B289E-03A0-43A8-813A-3A9324F20A66

Q30539133-2779A587-DC5E-44D0-BCF3-765E7D491E4C

Q30539133-2B961F35-6DC7-4232-8DAF-7C0B13C8BB18

P304

Q30539133-724EF2A0-611E-44F9-BF8D-0EE3A1D91DD9

P31

Q30539133-98CC7242-1EB4-491E-ACD5-4D000764FF09

P356

Q30539133-555E3433-6F20-4B45-A088-2E54E33D728A

P407

Q30539133-E0EA0151-3B56-458E-96D3-3AD813FE9505

P433

Q30539133-D537A764-2E7C-41A3-A6C2-80405443FAE6

P478

Q30539133-4C92E9C5-A92E-4969-81A1-F4066424DF0C

P50

Q30539133-E5AE943E-9F54-4112-A872-119C81538E3D

P577

Q30539133-AB5B7F75-CC09-4930-B6F0-E853F3B06AB1

P5875

Q30539133-570F33B2-E056-43D0-842A-7CFDC1A250E2

P698

Q30539133-3E6A574F-2EEF-4277-8DAA-6D301286B9D9

P921

Q30539133-C3FF03DF-15CB-4D39-9775-6025FB23F64E

P932

Q30539133-E5576068-24B6-4F20-8C77-CD91413F69F9

P356

P1433

P1476

Brain amyloid-β oligomers in ageing and Alzheimer's disease.

@en

P2093

Julie A Schneider

http://www.w3.org/2001/XMLSchema#string

Karen H Ashe

http://www.w3.org/2001/XMLSchema#string

Marianne Grant

http://www.w3.org/2001/XMLSchema#string

Mathew A Sherman

http://www.w3.org/2001/XMLSchema#string

Michael Kuskowski

http://www.w3.org/2001/XMLSchema#string

Sylvain E Lesné

http://www.w3.org/2001/XMLSchema#string

P2860

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Neuropathological stageing of Alzheimer-related changes

Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models

A specific amyloid-beta protein assembly in the brain impairs memory

Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia

Alzheimer's disease: the amyloid cascade hypothesis

P304

1383-1398

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWT062

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 5

http://www.w3.org/2001/XMLSchema#string

P478

136

http://www.w3.org/2001/XMLSchema#string

P50

David A Bennett

P577

2013-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236192637

http://www.w3.org/2001/XMLSchema#string

P698

23576130

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3634198

http://www.w3.org/2001/XMLSchema#string